Research from the UK suggests Pharmacy-led atrial fibrillation (AF) reviews have saved the NHS millions of pounds. The Stroke Association estimated that a pharmacist-led review of patients with AF saved over £82m in its first year of operations. The reviews weer...
The first example of a brand new therapeutic modality for the management of recurrent migraine has been approved for marketing by the US FDA. Although the safety profile of this approach and others that will follow has not yet been fully elucidated, it is likely that...
Lumbar puncture is sometimes indicated for patients taking both aspirin and clopidogrel. However, clinicians may have concerns about potential complications such as epidural haematomas, and literature is limited. Researchers performed a medical record review of...
A new monoclonal antibody against interleukin-4 and interleukin-13 has shown considerable potential to reduce asthma exacerbations, as well as the need for higher dose corticosteroid treatment. In view of the adverse effects associated with steroids, the promise of...
The US CDC has recently re-examined a decade of data about falls among older people – the leading cause of injury-related deaths among people aged ≥65 years. Deaths from falls among persons aged ≥65 years increased 31% from 2007 to 2016. The rate of deaths from falls...
